People who take Sinovac vaccine at higher risk of severe disease from Covid-19: Singapore study


Researchers found that the Sinovac vaccine was 60 per cent effective against severe disease from Covid-19. - ST

SINGAPORE (The Straits Times/Asia News Network): People who received two doses of China's Sinovac vaccine were more likely to develop severe disease from Covid-19 than those who got two shots of the mRNA-based Pfizer-BioNTech or Moderna vaccines, the National Centre for Infectious Diseases (NCID) has found.

"This supports the need for three doses of Sinovac-CoronaVac vaccine as a primary series," it said in a statement on Wednesday (Dec 15).

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Singapore , NCID , Sinovac , covid-19 , efficacy , study

   

Next In Aseanplus News

India protests over separatist slogans allowed at Toronto event
Saudi Crown Prince plans to visit Malaysia by year-end, says Anwar
Ex-civil servant arrested by MACC in Malay Reserve Land fraud
Asean News Headlines at 9pm on Monday (April 29, 2024)
Japan's ruling party loses all three seats in special vote, seen as punishment for corruption scandal
Order for Bung Moktar, wife to answer graft charges contrary to evidence, High Court rules
Singapore's S$3bil (RM10.5bil) money laundering case: Fourth man gets 14 months’ jail
Malaysian team loses 0-5 to Thailand in Uber Cup Finals second Group B match
Indonesia govt's proposed 40% debt to GDP in 2025 could risk overall economy, say experts
Malaysian deejay May Lau and husband hold traditional wedding ceremony in Nepal

Others Also Read